Janney Montgomery Scott
AGIO icon

Janney Montgomery Scott’s Agios Pharmaceuticals AGIO Stock Holding History

Janney Montgomery Scott’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,820
Closed -$248K – 1822
2017
Q2 		$248K Buy
4,820
+425
+10% +$21.7K ﹤0.01% 1530
2017
Q1 		$257K Buy
+4,395
New +$211K ﹤0.01% 1488

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janney Montgomery Scott's AGIO Position: Q3 2017 in Review

Janney Montgomery Scott sold out of Agios Pharmaceuticals (AGIO) in Q3 2017, closing a stake of 4,820 shares — an estimated $248K sold.

Janney Montgomery Scott first reported a position in AGIO in Q1 2017 and held it in 2 quarters. The position peaked at $257K in Q1 2017. 171 funds tracked by Wall St. Rank hold AGIO as of Q3 2017.

  • Janney Montgomery Scott reported no remaining Agios Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Janney Montgomery Scott sold 4,820 Agios Pharmaceuticals shares in Q3 2017, an estimated $248K.
  • Janney Montgomery Scott first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • Janney Montgomery Scott's Agios Pharmaceuticals position peaked at $257K in Q1 2017.
  • 171 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2017.

Based on Janney Montgomery Scott's 13F filing for Q3 2017, filed 15 Nov 2017.